Ascendiapharma
North Brunswick, US · Delaware corporation · 1 known investors
Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization. The company specializes in solving drug development challenges for small molecules, biologics, and gene delivery applications.
Founders & leadership
JH
Jingjun HuangFounder
Board
JG
RB
Robert BloderBoard director
MB
SL
Shoufeng LiBoard director
TO
Investors · 1
Reported raises · per SEC filings
Form D private placements$16.6M disclosed across 5 rounds · 2021–2026
▶$4.1MraisedJul 2026 · 3 investors · Other Health CareRule 506(b)
▶$4.1MraisedJul 2026 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jingjun HuangDirector
- Michael BogdaDirector
- James GaleDirector
- Robert BloderDirector
- Theron OdlaugDirector
- Shoufeng LiDirector
- Offering amount
- $4.1M
- Amount sold
- $4.1M
- Minimum investment
- $500K
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJun 2025 · 9 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedJun 2025 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shoufeng LiDirector
- James GaleDirector
- Jingjun HuangExecutive Officer, Director
- Theron OdlaugDirector
- Robert BloderDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $100K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.5MraisedOct 2024 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedOct 2024 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- James GaleDirector
- Shoufeng LiDirector
- Jingjun HuangExecutive Officer, Director
- Robert BloderDirector
- Theron OdlaugDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $475.1K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.5MraisedJul 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedJul 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Colin FosterDirector
- Theron OdlaugDirector
- Robert BloderDirector
- James GaleDirector
- Jingjun HuangExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $475K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$5MraisedApr 2021 · 2 investors · PharmaceuticalsRule 506(b)
▶$5MraisedApr 2021 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jingjun HuangExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $5M
- Minimum investment
- $950K
- Sales commissions
- $300K
- Placement agents
- Wombat Capital Markets LLC
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Ascendiapharma do?
- Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization. The company specializes in solving drug development challenges for small molecules, biologics, and gene delivery applications.
- Who founded Ascendiapharma?
- Ascendiapharma was founded by Jingjun Huang.
- Who are Ascendiapharma's investors?
- Ascendiapharma's investors include Signet Healthcare Partners.
- How much funding has Ascendiapharma raised?
- Ascendiapharma has disclosed $16.6M raised across 5 rounds.
- Where is Ascendiapharma headquartered?
- Ascendiapharma is headquartered in North Brunswick, US.